v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 25,268,225 $ 43,148,323
Restricted cash 126,174 124,102
Short-term investments 30,332,493 15,644,062
Prepaid research and development expenses 2,910 11,016
Other prepaid expenses and current assets 1,051,427 623,672
Total current assets 56,781,229 59,551,175
Property and equipment, net 1,607,582 1,609,679
Restricted cash, long-term 102,345 102,320
Operating lease right-of-use assets 742,503 775,085
TOTAL ASSETS 59,233,659 62,038,259
Current liabilities    
Accounts payable 1,446,592 2,202,149
Accrued expenses 3,089,302 3,973,941
Current portion of operating lease liabilities 138,623 134,801
Total current liabilities 4,674,517 6,310,891
Operating lease liabilities, net of current portion 631,388 667,632
TOTAL LIABILITIES 5,305,905 6,978,523
COMMITMENTS AND CONTINGENCIES (Note 4)
STOCKHOLDERS’ EQUITY    
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 181,622 shares issued and outstanding at March 31, 2023 and December 31, 2022 182 182
Common stock - $0.001 par value: 160,000,000 shares authorized; 44,499,788 and 42,815,196 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 44,500 42,815
Accumulated other comprehensive gain 101,232 82,743
Additional paid-in capital 339,709,852 330,294,782
Accumulated deficit (285,928,012) (275,360,786)
TOTAL STOCKHOLDERS’ EQUITY 53,927,754 55,059,736
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 59,233,659 $ 62,038,259